Author:
Cote David J.,Stampfer Meir J.,Egan Kathleen M.
Subject
Cancer Research,Oncology,Epidemiology
Reference5 articles.
1. Dabrafenib plus trametinib in patients with BRAF(V600E)-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial;Wen;Lancet Oncol.,2022
2. An independently validated survival nomogram for lower-grade glioma;Gittleman;Neuro-oncology,2020
3. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;Brat;N. Engl. J. Med.,2015
4. Management for different glioma subtypes: are all low-grade gliomas created equal? American Society of Clinical Oncology educational book;Tom;Am. Soc. Clin. Oncol.,2019
5. A prospective study of inflammatory biomarkers and growth factors and risk of glioma in the UK Biobank;Cote;Cancer Epidemiol.,2021